What is the generic name?

CERITINIB

What is the Trade Name for CERITINIB?

ZYKADIA

What are the Indications for CERITINIB?

• 1 INDICATIONS AND USAGE ZYKADIA ¬Æ is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test [see Dosage and Administration (2.1)] . ZYKADIA is a kinase inhibitor indicated for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. ( 1 , 2.1 )

References: https://open.fda.gov/